Adaptimmune Therapeutics plc - American Depositary Shares (ADAP) earnings
Quarterly and annual ADAP reports and results, each read against the price at its own news timestamp. Back to the ADAP overview →
8 measured ADAP earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Adaptimmune Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.77% | |
| Form 10-Q Adaptimmune Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +1.68% | +8.89% | |
| Form 10-K Adaptimmune Therapeutics For: Dec 31 | SEC filing · Form 10-K | +1.05% | -11.35% | |
| Form 10-Q Adaptimmune Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -8.03% | -27.01% | |
| Form 10-Q Adaptimmune Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +4.81% | +4.81% | |
| Form 10-Q Adaptimmune Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -5.22% | -10.45% | |
| Form 10-K Adaptimmune Therapeutics For: Dec 31 | SEC filing · Form 10-K | -5.66% | +7.55% | |
| Form 10-Q Adaptimmune Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +3.80% | -0.64% |
Keep exploring
More ADAP: analyst actions → · SEC filings → · ADAP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Zomedica Corp. Common Shares (ZOM) | 161 | +0.08% | 53% |
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
| DURECT Corporation (DRRX) | 159 | +0.03% | 51% |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.